Healthcare
Rafina Innovations Inc.(VICA)
Live Price
Offline$0.001
+0.00% today
1Y Change
+900.00%
Window
Jun 23, 2025 → Jun 12, 2026
- Market Cap
- —
- Revenue Growth
- 0.0%
- EPS Growth
- -226.5%
- Dividend Yield
- 0.0%
Coverage: 248 bars · Jun 23, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Rafina Innovations Inc. (VICA) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 900.0% across the available one-year price window (Jun 23, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -226.5%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -226.5%, free cash flow -2163.3% with operating margin -26.6% and ROIC -19.6%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines VICA price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
0.0% vs +7.6% peer median
Operating Margin
Below sector median
-26.6% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The operating picture looks softer than before
Revenue is at 0.0% and EPS is at -226.5%, with operating margin around -26.6%.
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
VICA
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
VICA Max Drawdown
-70.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for VICA and SPY.
Company Overview
Rafina Innovations Inc.
Other OTC
Rafina Innovations Inc. engages in the research, development, commercialization, and marketing of medical technologies. It operates through two segments, Clinics and Technology. The company also operates prosthetics and orthotics, and diabetic foot total rehabilitation clinics in Southern Europe, the Middle East, and North Africa. In addition, it is involved in the research, development, and commercialization of medical devices, methods, and products in the fields of prosthetics, orthotics, rehabilitation, bioengineering, mobility, diabetes, diabetic foot, tissue mechanics, ultrasonics, medical signal processing and analysis, medical technology, orthopedics, and robotic surgery; and licensing of its proprietary technologies. The company was formerly known as HCi Viocare and changed its name to Rafina Innovations Inc. in July 2018. Rafina Innovations Inc. was founded in 2007 and is based in Glasgow, the United Kingdom.
- Leadership
- Nikolaos Kardaras
- IPO Date
- Oct 23, 2013
- Employees
- 4
- Street Address
- Kintyre House
- Mailing
- Glasgow, G51 1HJ
- Region
- Glasgow, GB
- Reporting Currency
- USD
- Investor Line
- 44 1413 700 321
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- —
- EV/EBITDA
- —
- Price/Sales
- 0.0
- Price/Book
- 0.0
Growth
- Revenue
- 0.0%
- EPS
- -226.5%
- Free Cash Flow
- -2163.3%
Profitability
- Gross Margin
- -5.2%
- Operating Margin
- -26.6%
- Net Margin
- -26.9%
- ROE
- -55.5%
- ROIC
- -19.6%
Balance Sheet
- Debt/Equity
- 0.08
- Current Ratio
- 1.18
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.